Faculty Affairs News Supporting and Celebrating Faculty Success at UTMB
A Message from the Senior Vice President and Provost (interim):
Updates from the Office of Innovation
Welcome, Prenaital!
Prenaital, a Denmark start-up company that develops AI models to improve diagnostics of pregnant women, and the Consulate General of Denmark-Houston visited UTMB on February 11, 2025.
UTMB's AI Team, OB/GYN physicians, and the Office of Innovation provided feedback and collaboration opportunities with UTMB faculty to better understand the US market for their companies’ diagnostic solutions.
Announcing the UTMB Innovation Advisory Board
The Office of Innovation has constituted this new group of industry leaders to advise us on commercialization opportunities for UTMB faculty and technologies.
Murali Gopalakrishnan, PhD – Abbvie
Julio Medina, PhD – R2M Pharma
Jakob Dupont, MD - Soffinova
William McKeon – Texas Medical Center
Pei Yong Shi, PhD – GSK
James Galbraith – MAPA Law Firm
Sanja Sever, PhD – Vice President for Drug Discovery and Director of the Sealy Institute for Drug Discovery, UTMB
Prenaital, a Denmark start-up company that develops AI models to improve diagnostics of pregnant women, and the Consulate General of Denmark-Houston visited UTMB on February 11, 2025.
UTMB's AI Team, OB/GYN physicians, and the Office of Innovation provided feedback and collaboration opportunities with UTMB faculty to better understand the US market for their companies’ diagnostic solutions.
Announcing the UTMB Innovation Advisory Board
The Office of Innovation has constituted this new group of industry leaders to advise us on commercialization opportunities for UTMB faculty and technologies.
Murali Gopalakrishnan, PhD – Abbvie
Julio Medina, PhD – R2M Pharma
Jakob Dupont, MD - Soffinova
William McKeon – Texas Medical Center
Pei Yong Shi, PhD – GSK
James Galbraith – MAPA Law Firm
Sanja Sever, PhD – Vice President for Drug Discovery and Director of the Sealy Institute for Drug Discovery, UTMB
Health Education Center (HEC)
Updates from the Office of Innovation
Welcome, Prenaital!
Prenaital, a Denmark start-up company that develops AI models to improve diagnostics of pregnant women, and the Consulate General of Denmark-Houston visited UTMB on February 11, 2025.
UTMB's AI Team, OB/GYN physicians, and the Office of Innovation provided feedback and collaboration opportunities with UTMB faculty to better understand the US market for their companies’ diagnostic solutions.
Announcing the UTMB Innovation Advisory Board
The Office of Innovation has constituted this new group of industry leaders to advise us on commercialization opportunities for UTMB faculty and technologies.
Murali Gopalakrishnan, PhD – Abbvie
Julio Medina, PhD – R2M Pharma
Jakob Dupont, MD - Soffinova
William McKeon – Texas Medical Center
Pei Yong Shi, PhD – GSK
James Galbraith – MAPA Law Firm
Sanja Sever, PhD – Vice President for Drug Discovery and Director of the Sealy Institute for Drug Discovery, UTMB
Prenaital, a Denmark start-up company that develops AI models to improve diagnostics of pregnant women, and the Consulate General of Denmark-Houston visited UTMB on February 11, 2025.
UTMB's AI Team, OB/GYN physicians, and the Office of Innovation provided feedback and collaboration opportunities with UTMB faculty to better understand the US market for their companies’ diagnostic solutions.
Announcing the UTMB Innovation Advisory Board
The Office of Innovation has constituted this new group of industry leaders to advise us on commercialization opportunities for UTMB faculty and technologies.
Murali Gopalakrishnan, PhD – Abbvie
Julio Medina, PhD – R2M Pharma
Jakob Dupont, MD - Soffinova
William McKeon – Texas Medical Center
Pei Yong Shi, PhD – GSK
James Galbraith – MAPA Law Firm
Sanja Sever, PhD – Vice President for Drug Discovery and Director of the Sealy Institute for Drug Discovery, UTMB
Prenaital, a Denmark start-up company that develops AI models to improve diagnostics of pregnant women, and the Consulate General of Denmark-Houston visited UTMB on February 11, 2025.
UTMB's AI Team, OB/GYN physicians, and the Office of Innovation provided feedback and collaboration opportunities with UTMB faculty to better understand the US market for their companies’ diagnostic solutions.
Announcing the UTMB Innovation Advisory Board
The Office of Innovation has constituted this new group of industry leaders to advise us on commercialization opportunities for UTMB faculty and technologies.
Murali Gopalakrishnan, PhD – Abbvie
Julio Medina, PhD – R2M Pharma
Jakob Dupont, MD - Soffinova
William McKeon – Texas Medical Center
Pei Yong Shi, PhD – GSK
James Galbraith – MAPA Law Firm
Sanja Sever, PhD – Vice President for Drug Discovery and Director of the Sealy Institute for Drug Discovery, UTMB
The Office of Biostatistics (OBIOS) will host an open house for the UTMB community to learn more about their office and services. OBIOS collaborates with departments and centers across UTMB to support impactful public health and clinical research.
The Graduate School of Biomedical Sciences has announced the date for the 2025 GSBS Research Expo. The expo provides an opportunity for GSBS trainees to present their research, network with faculty and trainees from across the UTMB campus, and more.
News and Awards
Updates from the Office of Innovation
Welcome, Prenaital!
Prenaital, a Denmark start-up company that develops AI models to improve diagnostics of pregnant women, and the Consulate General of Denmark-Houston visited UTMB on February 11, 2025.
UTMB's AI Team, OB/GYN physicians, and the Office of Innovation provided feedback and collaboration opportunities with UTMB faculty to better understand the US market for their companies’ diagnostic solutions.
Announcing the UTMB Innovation Advisory Board
The Office of Innovation has constituted this new group of industry leaders to advise us on commercialization opportunities for UTMB faculty and technologies.
Murali Gopalakrishnan, PhD – Abbvie
Julio Medina, PhD – R2M Pharma
Jakob Dupont, MD - Soffinova
William McKeon – Texas Medical Center
Pei Yong Shi, PhD – GSK
James Galbraith – MAPA Law Firm
Sanja Sever, PhD – Vice President for Drug Discovery and Director of the Sealy Institute for Drug Discovery, UTMB
Research and Innovations
News and Events
Updates from the Office of Innovation
Welcome, Prenaital!
Prenaital, a Denmark start-up company that develops AI models to improve diagnostics of pregnant women, and the Consulate General of Denmark-Houston visited UTMB on February 11, 2025.
UTMB's AI Team, OB/GYN physicians, and the Office of Innovation provided feedback and collaboration opportunities with UTMB faculty to better understand the US market for their companies’ diagnostic solutions.
Announcing the UTMB Innovation Advisory Board
The Office of Innovation has constituted this new group of industry leaders to advise us on commercialization opportunities for UTMB faculty and technologies.
Murali Gopalakrishnan, PhD – Abbvie
Julio Medina, PhD – R2M Pharma
Jakob Dupont, MD - Soffinova
William McKeon – Texas Medical Center
Pei Yong Shi, PhD – GSK
James Galbraith – MAPA Law Firm
Sanja Sever, PhD – Vice President for Drug Discovery and Director of the Sealy Institute for Drug Discovery, UTMB
We are thrilled to announce our inaugural UTMB Innovation summit. This event will bring together a dynamic community of innovators, entrepreneurs, researchers, and investors. We plan to discuss the fast-growing Biotech economy in Texas, current investment themes and opportunities and market outlook.
The next Faculty Advancement in Research (FAIR) Seminar will be: "Gulf Coast Consortia: Cultivating Inter-Institutional Collaborations Since 1990" presented by Karen Ethun, Executive Director, Gulf Coast Consortia.
This in-person, six-hour, evidence-based workshop helps develop skills and insights in mentoring through interactions and discussions.
Do you have an item for our Faculty Affairs newsletter? Please provide your submissions by July 20 to be considered for publication in the next edition.
-(1).png?sfvrsn=34cc055_4 "May 2025 (1) (1)")
